Guessing is not a strategy: How to build decision velocity with AI and real-time data
June 10, 2026 | Live Webinar
Pharmaceutical Firms Face Portfolio Challenges
More than 76 percent find collecting the information needed to make effective portfolio management decisions to be highly difficult, survey finds.
The majority of pharmaceutical organizations are confident in the maturity of their portfolio management practices, yet more than 76 percent find collecting the information needed to make effective portfolio management decisions to be highly difficult, according to a recent survey by Artemis International Solutions Corporation. The survey, which included 84 responding firms from pharmaceutical, biopharmaceutical and biotechnology industries, was designed to evaluate the current portfolio management practices and challenges in the market.
"The results of this survey confirmed what we’ve learned from our customers," said Patrick Ternier, CEO and president of Artemis, provider of the Artemis 7 portfolio management solution. "Pharmaceutical firms are further along the maturity scale then many other industries, but continue to suffer from the lack of a comprehensive, integrated framework for portfolio data management."
While over 80 percent indicated that they have a consistent way to capture projected risks, costs, benefits and the strategic value of all projects, almost 50 percent indicated that they do not have an effective process for communicating this type of portfolio information across multiple business lines, development…
Please log in or sign up below to read the rest of the article.
ADVERTISEMENTS
|
"Life is but a walking shadow, a poor player that struts and frets his hour upon the stage and then is heard of no more. It is a tale told by an idiot, full of sound and fury, signifying nothing." - William Shakespeare |